StocksRunner logo
mail
search
 
menu
 
Cigna
$316.64
+1.47%
 
  Create Alerts  
  
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
 
 

CI

 

Cigna

$316.64

 
+$4.59 | +1.47%
 
  Create Alerts  
  
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 370.83
 
 
MKT CAP
$ 84.59B
 
52W Low
$ 262.03
 
 
VOL
$ 2.66M
 
P/E Ratio
17.54
 
 
AVG VOL
$ 1.76M
 
RSI
46.71
 
 
TREND
Sideways
 
 
 

Chart

 
 

$324.54   (-2.43%)

$326.68   (-3.07%)

$295.15   (+7.28%)

$333.9   (-5.17%)

 
 
1year
6month
3month
1month
 
CI Latest Headlines +
 
 
 
StocksRunner

Explore our CI Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored CI Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our CI Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
 

CI

 

Cigna

 

Current Price

 

$316.64

 
+$4.59 | +1.47%
 
 
52W High
$ 370.83
 
 
MKT CAP
$ 84.59B
 
52W Low
$ 262.03
 
 
VOL
$ 2.66M
 
P/E Ratio
17.54
 
 
AVG VOL
$ 1.76M
 
RSI
46.71
 
 
TREND
Sideways
 
 
 
  Create Alerts  
  
  Overview  
  
  Analysis  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 
 
 

CI Stock Analysis for the Last 90 Days

 
lock  Login to view Cigna (CI) recommendation from the last 90 days from financial news and social media.
 

Chart

 
 

$324.54   (-2.43%)

$326.68   (-3.07%)

$295.15   (+7.28%)

$333.9   (-5.17%)

 
 
1year
6month
3month
1month
 
 
 
 
 

CI Latest Headlines

 
 
 

Heres How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today. Cigna Group (NYSE:) has outperformed the market over the past 15 years by 3.91% on an annualized basis producing an average annual return of 16.06%. Currently Cigna Group has a market capitalization of $85.84 billion.

 

Today

$316.64 | +1.47%
 
Activity

CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?. CVS rallies on turnaround momentum and EPS growth while CI is a defensive play with stable returns and a focused healthcare strategy.

 

Wed May 28, 2025

$310.81 | -1.40%
 
Earnings
Momentum

CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?. CVS rallies on turnaround momentum and EPS growth while CI is a defensive play with stable returns and a focused healthcare strategy.

 

Wed May 28, 2025

$310.81 | -1.40%
 
Earnings
Momentum

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs. Cignas pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

 

Wed May 21, 2025

$317.14 | -2.42%
 
Activity

MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS. Marpai'.s turnaround momentum is building) a leader in innovative healthcare technology and Third-Party Administration (TPA) services announced financial results for the first quarter of 2025. The Company expects to hold a webcast to discuss the results on Marpai CEO Q1 2025 Financial Highlights:Net revenues were approximately Operating expenses were Operating loss was Net loss was Basic and diluted earnings per share were The Company had W

 

Wed May 14, 2025

$303.52 | +0.53%
 
Activity
Earnings
Potential

MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS. Marpai'.s turnaround momentum is building) a leader in innovative healthcare technology and Third-Party Administration (TPA) services announced financial results for the first quarter of 2025. The Company expects to hold a webcast to discuss the results on Marpai CEO Q1 2025 Financial Highlights:Net revenues were approximately Operating expenses were Operating loss was Net loss was Basic and diluted earnings per share were The Company had W

 

Wed May 14, 2025

$303.52 | +0.53%
 
Activity
Earnings
Potential

MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS. Marpai'.s turnaround momentum is building) a leader in innovative healthcare technology and Third-Party Administration (TPA) services announced financial results for the first quarter of 2025. The Company expects to hold a webcast to discuss the results on Marpai CEO Q1 2025 Financial Highlights:Net revenues were approximately Operating expenses were Operating loss was Net loss was Basic and diluted earnings per share were The Company had W

 

Wed May 14, 2025

$303.52 | +0.53%
 
Activity
Earnings
Potential

The Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical Officer. CERRITOS Calif. May 14 2025 (GLOBE NEWSWIRE) -- The Oncology Institute Inc. (NASDAQ:) (TOI) one of the largest value-based oncology groups in the United States announced today that Dr. Jeffrey Langsam will assume the role of enterprise Chief Clinical Officer effective May 13th 2025. The CCO role will oversee therapeutics including pathway and procurement decisions utilization management and MSO practice clinical engageme

 

Wed May 14, 2025

$303.52 | +0.53%
 
Activity

Why Cigna Group Stock Dived Today. Monday wasnt a very good day for health insurers and if a days not good for health insurers you can bet Cigna Group (NYSE: CI) stock took it on the chin.

 

Mon May 12, 2025

$315.74 | -5.31%
 
Potential
Potential

Why Cigna Group Stock Dived Today. Monday wasnt a very good day for health insurers and if a days not good for health insurers you can bet Cigna Group (NYSE: CI) stock took it on the chin.

 

Mon May 12, 2025

$315.74 | -5.31%
 
Potential
Potential

 
 
 
 
 
StocksRunner

Discover CI Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CI. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our CI Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CI Stock trends

CI Stock performance

CI Stock analysis

CI investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

UnAlert CI Runner Alarm

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 

 
 
Post ×
 
0/666
joker
 
 
 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CI

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

 
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing CI

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.